Get Live Data

Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Astrazeneca Share Price
  4. Astrazeneca Share News
  5. UPDATE: BROKER RATINGS SUMMARY: Buy Wolseley, Sell Berkeley - Goldman

Pin to quick picksAstrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE: BROKER RATINGS SUMMARY: Buy Wolseley, Sell Berkeley - Goldman

Wed, 29th Jun 2016 14:39

LONDON (Alliance News) - The following shares received analyst recommendations Monday afternoon and morning:
----------
FTSE 100
----------
GOLDMAN RAISES WOLSELEY TO 'BUY' ('NEUTRAL') - TARGET 4,226 (4,294) PENCE
----------
GOLDMAN CUTS BERKELEY GROUP TO 'SELL' ('NEUTRAL') - TARGET 2,110 (4,000) PENCE
----------
GOLDMAN CUTS PERSIMMON PRICE TARGET TO 1,269 (2,280) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 365 (698) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS TAYLOR WIMPEY PRICE TARGET TO 123 (231) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS TRAVIS PERKINS PRICE TARGET TO 1,452 (2,236) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS INTU PROPERTIES PRICE TARGET TO 314 (350) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS LAND SECURITIES PRICE TARGET TO 1,200 (1,410) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS HAMMERSON PRICE TARGET TO 670 (750) PENCE - 'BUY'
----------
GOLDMAN CUTS BRITISH LAND CO PRICE TARGET TO 736 (910) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ARM HOLDINGS TO 'BUY' (CONVICTION BUY) - PRICE TARGET 1275 (1400) PENCE
----------
SHORE CAPITAL RAISES PROVIDENT FINANCIAL TO 'BUY' ('HOLD')
----------
GOLDMAN CUTS WHITBREAD PRICE TARGET TO 3,910 (4,490) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES INTERCONTINENTAL HOTELS TARGET TO 3,120 (3,090)P - 'NEUTRAL'
----------
GOLDMAN CUTS EASYJET TO 'BUY' ('CONVICTION BUY') - TARGET 1,310 (1,740) PENCE
----------
GOLDMAN RESUMES SHIRE WITH 'CONVICTION BUY LIST' - TARGET 6,300 PENCE
----------
GOLDMAN RAISES ASTRAZENECA PRICE TARGET TO 4000 (3700) PENCE - 'SELL'
----------
GOLDMAN RAISES RELX TARGET TO 1360 (1320) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES PEARSON PRICE TARGET TO 845 (800) PENCE - 'SELL'
----------
GOLDMAN CUTS INFORMA PRICE TARGET TO 836 (839) PENCE - 'CONVICTION BUY LIST'
----------
GOLDMAN CUTS ITV PRICE TARGET TO 198 (258) PENCE - 'BUY'
----------
GOLDMAN CUTS WPP PRICE TARGET TO 1,800 (1,860) PENCE - 'BUY'
----------
GOLDMAN CUTS SKY PRICE TARGET TO 1013 (1254) PENCE - 'BUY'
----------
GOLDMAN CUTS SCHRODERS PRICE TARGET TO 2,800 (3,400) PENCE - 'BUY'
----------
GOLDMAN CUTS VODAFONE PRICE TARGET TO 260 (265) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BT GROUP PRICE TARGET TO 540 (650) PENCE - 'CONVICTION BUY LIST'
----------
FTSE 250
----------
GOLDMAN CUTS COUNTRYWIDE TO 'SELL' ('NEUTRAL') - TARGET 218 (465) PENCE
----------
GOLDMAN RAISES GREAT PORTLAND TO 'NEUTRAL' ('SELL') - TARGET 690 (850) PENCE
----------
GOLDMAN RAISES DERWENT LONDON TO 'BUY' ('NEUTRAL') - TARGET 3,100 (3,815) PENCE
----------
GOLDMAN CUTS CREST NICHOLSON TO 'NEUTRAL' ('CONVICTION BUY') CUTS PRICE TARGET TO 384 (755) PENCE
----------
GOLDMAN CUTS BELLWAY TO 'NEUTRAL' ('BUY') - TARGET 1,715 (3,590) PENCE
----------
GOLDMAN CUTS REDROW TO 'NEUTRAL' ('BUY') - TARGET 301 (595) PENCE
----------
GOLDMAN CUTS MCCARTHY & STONE PRICE TARGET TO 161 (275) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BOVIS HOMES TO 'NEUTRAL' ('BUY') - TARGET 684 (1,320) PENCE
----------
GOLDMAN RAISES SHAFTESBURY PRICE TARGET TO 1,061 (1,026) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS SEGRO PRICE TARGET TO 475 (555) PENCE - 'BUY'
----------
GOLDMAN CUTS HOWDEN JOINERY GROUP PRICE TARGET TO 376 (515) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS AA PRICE TARGET TO 340 (390) PENCE - 'BUY'
----------
GOLDMAN CUTS WILLIAM HILL PRICE TARGET TO 310 (380) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ASCENCIAL TARGET TO 269 (278) PENCE - 'BUY'
----------
GOLDMAN RAISES UBM PRICE TARGET TO 750,37 (690,70) PENCE - 'BUY'
----------
GOLDMAN CUTS TULLETT PREBON PRICE TARGET TO 315 (390) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ICAP PRICE TARGET TO 460 (520) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS MAN GROUP PRICE TARGET TO 155 (200) PENCE - 'CONVICTION BUY LIST'
----------
GOLDMAN CUTS INTERMEDIATE CAPITAL PRICE TARGET TO 565 (685) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ASHMORE GROUP PRICE TARGET TO 310 (325) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ABERDEEN ASSET MANAG PRICE TARGET TO 270 (288) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
GOLDMAN CUTS SECURE INCOME TO 'NEUTRAL' ('BUY') - TARGET 308 (355) PENCE
----------
GOLDMAN CUTS DAILY MAIL PRICE TARGET TO 584 (628) PENCE - 'SELL'
----------
GOLDMAN CUTS FOXTONS TO 'SELL' ('NEUTRAL') - TARGET 96 (198) PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.